Erratum: The phosphoinositide 3-kinase a selective inhibitor BYL719 enhances the effect of the protein kinase C inhibitor AEB071 in GNAQ/GNA11-mutant uveal melanoma cells (Molecular Cancer Therapeutics (2014) 13 (2250))

E. Musi; G. Ambrosini; E. De Stanchina; G. K. Schwartz

doi:10.1158/1535-7163.MCT-14-0586

Erratum: The phosphoinositide 3-kinase a selective inhibitor BYL719 enhances the effect of the protein kinase C inhibitor AEB071 in GNAQ/GNA11-mutant uveal melanoma cells (Molecular Cancer Therapeutics (2014) 13 (2250))

E. Musi, G. Ambrosini, E. De Stanchina, G. K. Schwartz

Icahn School of Medicine at Mount Sinai

Research output: Contribution to journal › Comment/debate

Original language	English
Pages (from-to)	2250
Number of pages	1
Journal	Molecular Cancer Therapeutics
Volume	13
Issue number	9
DOIs	https://doi.org/10.1158/1535-7163.MCT-14-0586
State	Published - 1 Sep 2014

Access to Document

10.1158/1535-7163.MCT-14-0586

Cite this

Musi, E., Ambrosini, G., De Stanchina, E., & Schwartz, G. K. (2014). Erratum: The phosphoinositide 3-kinase a selective inhibitor BYL719 enhances the effect of the protein kinase C inhibitor AEB071 in GNAQ/GNA11-mutant uveal melanoma cells (Molecular Cancer Therapeutics (2014) 13 (2250)). Molecular Cancer Therapeutics, 13(9), 2250. https://doi.org/10.1158/1535-7163.MCT-14-0586

@article{a6a8f51c2c9543a8a2710a72484d6908,

title = "Erratum: The phosphoinositide 3-kinase a selective inhibitor BYL719 enhances the effect of the protein kinase C inhibitor AEB071 in GNAQ/GNA11-mutant uveal melanoma cells (Molecular Cancer Therapeutics (2014) 13 (2250))",

author = "E. Musi and G. Ambrosini and {De Stanchina}, E. and Schwartz, {G. K.}",

year = "2014",

month = sep,

day = "1",

doi = "10.1158/1535-7163.MCT-14-0586",

language = "English",

volume = "13",

pages = "2250",

journal = "Molecular Cancer Therapeutics",

issn = "1535-7163",

publisher = "American Association for Cancer Research Inc.",

number = "9",

}

Musi, E, Ambrosini, G, De Stanchina, E & Schwartz, GK 2014, 'Erratum: The phosphoinositide 3-kinase a selective inhibitor BYL719 enhances the effect of the protein kinase C inhibitor AEB071 in GNAQ/GNA11-mutant uveal melanoma cells (Molecular Cancer Therapeutics (2014) 13 (2250))', Molecular Cancer Therapeutics, vol. 13, no. 9, pp. 2250. https://doi.org/10.1158/1535-7163.MCT-14-0586

Erratum: The phosphoinositide 3-kinase a selective inhibitor BYL719 enhances the effect of the protein kinase C inhibitor AEB071 in GNAQ/GNA11-mutant uveal melanoma cells (Molecular Cancer Therapeutics (2014) 13 (2250)). / Musi, E.; Ambrosini, G.; De Stanchina, E. et al.
In: Molecular Cancer Therapeutics, Vol. 13, No. 9, 01.09.2014, p. 2250.

Research output: Contribution to journal › Comment/debate

TY - JOUR

T1 - Erratum

T2 - The phosphoinositide 3-kinase a selective inhibitor BYL719 enhances the effect of the protein kinase C inhibitor AEB071 in GNAQ/GNA11-mutant uveal melanoma cells (Molecular Cancer Therapeutics (2014) 13 (2250))

AU - Musi, E.

AU - Ambrosini, G.

AU - De Stanchina, E.

AU - Schwartz, G. K.

PY - 2014/9/1

Y1 - 2014/9/1

UR - http://www.scopus.com/inward/record.url?scp=84907188999&partnerID=8YFLogxK

U2 - 10.1158/1535-7163.MCT-14-0586

DO - 10.1158/1535-7163.MCT-14-0586

M3 - Comment/debate

AN - SCOPUS:84907188999

SN - 1535-7163

VL - 13

SP - 2250

JO - Molecular Cancer Therapeutics

JF - Molecular Cancer Therapeutics

IS - 9

ER -